Trial Profile
Open clinical study on the efficacy and tolerability of buprenorfina tds transtec as first line opioid W.H.O. ladder s 3rd step for the medium-long term pain treatment in patients with solid advanced tumors.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2011
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Cancer pain
- Focus Adverse reactions; Therapeutic Use
- 12 May 2011 New trial record